A - Human Necessities – 61 – B
Patent
A - Human Necessities
61
B
A61B 5/00 (2006.01) A61M 37/00 (2006.01) A61N 1/30 (2006.01)
Patent
CA 2641359
Neurological diseases, including lysosomal storage diseases, can be successfully treated using intraventricular delivery of the therapeutic agents to bypass the blood-brain barrier. Similarly, diagnostic agents and anesthetic agents can be delivered to the brain in this manner. The administration can be performed slowly to achieve maximum effect. Such administration permits greater penetration of distal portions of the brain.
Des maladies neurologiques, y compris des maladies lysosomales, peuvent être traitées avec succès par administration intraventriculaire d'agents thérapeutiques afin d'éviter la barrière hématoméningée. De même, des agents diagnostiques et des agents anesthésiques peuvent être administrés au cerveau de cette manière. L'administration peut être réalisée lentement pour obtenir un effet maximum. Une telle administration permet une plus grande pénétration des portions distales du cerveau.
Cheng Seng
Dodge James
Passini Marco
Shihabuddin Lamya
Genzyme Corporation
Gowling Lafleur Henderson Llp
LandOfFree
Slow intraventricular delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Slow intraventricular delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Slow intraventricular delivery will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1864664